Skip header and navigation

Refine By

   MORE

14 records – page 1 of 2.

[Additional millions added to Swedish HIV/AIDS research should reduce the increase in AIDS epidemiology]

https://arctichealth.org/en/permalink/ahliterature8603
Source
Lakartidningen. 1988 Jun 22;85(25):2276-8
Publication Type
Article
Date
Jun-22-1988
Author
H. Wigzell
Source
Lakartidningen. 1988 Jun 22;85(25):2276-8
Date
Jun-22-1988
Language
Swedish
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - economics - epidemiology
Humans
Research Support - economics
Sweden
PubMed ID
3386356 View in PubMed
Less detail

[AIDS. Epidemiology and social perspectives]

https://arctichealth.org/en/permalink/ahliterature8769
Source
Ugeskr Laeger. 1986 Mar 31;148(14):855-60
Publication Type
Article
Date
Mar-31-1986

AIDS in the US: a decade of fear and cruel indifference.

https://arctichealth.org/en/permalink/ahliterature220137
Source
CMAJ. 1993 Oct 1;149(7):1019-22
Publication Type
Article
Date
Oct-1-1993
Source
Harv Bus Rev. 2003 Feb;81(2):80-7, 125
Publication Type
Article
Date
Feb-2003
Author
Sydney Rosen
Jonathon Simon
Jeffrey R Vincent
William MacLeod
Matthew Fox
Donald M Thea
Author Affiliation
Boston University School of Public Health's Center for International Health, USA.
Source
Harv Bus Rev. 2003 Feb;81(2):80-7, 125
Date
Feb-2003
Language
English
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - economics - epidemiology - prevention & control
Adult
Antiretroviral Therapy, Highly Active - economics
Botswana - epidemiology
Commerce - economics
Cost Savings
Cost-Benefit Analysis
Developing Countries - economics
Employer Health Costs
Employment
HIV Infections - drug therapy - economics - epidemiology
Humans
Internationality
Investments - economics
Middle Aged
Occupational Health Services - economics
Research Support, U.S. Gov't, Non-P.H.S.
South Africa - epidemiology
Abstract
If your company operates in a developing country, AIDS is your business. While Africa has received the most attention, AIDS is also spreading swiftly in other parts of the world. Russia and Ukraine had the fastest-growing epidemics last year, and many experts believe China and India will suffer the next tidal wave of infection. Why should executives be concerned about AIDS? Because it is destroying the twin rationales of globalization strategy-cheap labor and fast-growing markets--in countries where people are heavily affected by the epidemic. Fortunately, investments in programs that prevent infection and provide treatment for employees who have HIV/AIDS are profitable for many businesses--that is, they lead to savings that outweigh the programs' costs. Due to the long latency period between HIV infection and the onset of AIDS symptoms, a company is not likely to see any of the costs of HIV/AIDS until five to ten years after an employee is infected. But executives can calculate the present value of epidemic-related costs by using the discount rate to weigh each cost according to its expected timing. That allows companies to think about expenses on HIV/AIDS prevention and treatment programs as investments rather than merely as costs. The authors found that the annual cost of AIDS to six corporations in South Africa and Botswana ranged from 0.4% to 5.9% of the wage bill. All six companies would have earned positive returns on their investments if they had provided employees with free treatment for HIV/AIDS in the form of highly active antiretroviral therapy (HAART), according to the mathematical model the authors used. The annual reduction in the AIDS "tax" would have been as much as 40.4%. The authors' conclusion? Fighting AIDS not only helps those infected; it also makes good business sense.
PubMed ID
12577655 View in PubMed
Less detail
Source
CMAJ. 1993 Mar 1;148(5):802-5
Publication Type
Article
Date
Mar-1-1993
Author
M T Schechter
Author Affiliation
Department of Health Care and Epidemiology, Faculty of Medicine, University of British Columbia.
Source
CMAJ. 1993 Mar 1;148(5):802-5
Date
Mar-1-1993
Language
English
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - economics - epidemiology - microbiology - prevention & control - transmission
Attitude to Health
Canada - epidemiology
Costs and Cost Analysis
Disease Outbreaks
HIV
Health Priorities
Health Resources
Humans
Incidence
Research Support as Topic
Notes
Cites: CMAJ. 1988 Apr 15;138(8):736-413355954
Cites: Science. 1988 Jul 29;241(4865):514, 5173399880
Comment In: CMAJ. 1993 Aug 1;149(3):265, 268; author reply 268-98339169
Comment In: CMAJ. 1993 Mar 1;148(5):745-98439932
Comment In: CMAJ. 1993 Aug 1;149(3):265; author reply 268-98339168
PubMed ID
8439940 View in PubMed
Less detail

Canadian experiences with AIDS and HIV infection.

https://arctichealth.org/en/permalink/ahliterature231601
Source
Bull Pan Am Health Organ. 1989;23(1-2):1-8
Publication Type
Article
Date
1989
Author
A. Adrien
C. Hankins
R. Remis
Source
Bull Pan Am Health Organ. 1989;23(1-2):1-8
Date
1989
Language
English
Publication Type
Article
Keywords
AIDS Serodiagnosis
Acquired Immunodeficiency Syndrome - economics - epidemiology
Adult
Canada
Child
Costs and Cost Analysis
Health education
Humans
International Cooperation
Mass Screening
Population Surveillance
Research
Abstract
Canada's first AIDS case was diagnosed in 1978, and a total of 2,003 cases had been recorded up to 19 September 1988. Nationwide, 82% of those afflicted have been homosexual or bisexual men, 5% have been immigrants from endemic regions, and 4.6% have been recipients of blood or blood products. Estimates of Canadians infected with HIV range from 10,000 to 50,000. A system of voluntary testing of individuals, combined with anonymous screening of populations for epidemiologic purposes, comprises the HIV testing program in Canada. Most major cities have volunteer AIDS support committees conducting education, advocacy, and support activities; Can$48 million has been allocated to educate the public about AIDS over the next five years. Research and international cooperation are also receiving increased priority and funding.
PubMed ID
2720233 View in PubMed
Less detail

[Denmark in 10 years: an entire hospital filled with AIDS patients?]

https://arctichealth.org/en/permalink/ahliterature8725
Source
Sykepleien. 1987 May 22;74(9):24-30
Publication Type
Article
Date
May-22-1987
Author
G. Bolstad
Source
Sykepleien. 1987 May 22;74(9):24-30
Date
May-22-1987
Language
Norwegian
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - economics - epidemiology - nursing
Denmark
Health Expenditures
Humans
Social Support
PubMed ID
3110987 View in PubMed
Less detail

Economic toll of AIDS put at $10 billion in Canada.

https://arctichealth.org/en/permalink/ahliterature210539
Source
AIDS Policy Law. 1996 Nov 29;11(21):12-3
Publication Type
Article
Date
Nov-29-1996
Source
AIDS Policy Law. 1996 Nov 29;11(21):12-3
Date
Nov-29-1996
Language
English
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - economics - epidemiology
Canada - epidemiology
Humans
PubMed ID
11364044 View in PubMed
Less detail

The HIV/AIDS epidemic in Ukraine: its potential social and economic impact.

https://arctichealth.org/en/permalink/ahliterature7487
Source
Soc Sci Med. 2000 Nov;51(9):1387-403
Publication Type
Article
Date
Nov-2000
Author
T. Barnett
A. Whiteside
L. Khodakevich
Y. Kruglov
V. Steshenko
Author Affiliation
School of Development Studies, University of East Anglia, Norwich, UK. a.barnett@uea.ac.uk
Source
Soc Sci Med. 2000 Nov;51(9):1387-403
Date
Nov-2000
Language
English
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - economics - epidemiology - mortality - transmission
Adolescent
Adult
Aged
Blood Donors
Byelarus - epidemiology
Child
Comparative Study
Disease Outbreaks
Female
Foster Home Care
HIV Infections - economics - epidemiology - transmission
Health Services - utilization
Hospitalization - statistics & numerical data
Humans
Income
Male
Moldova - epidemiology
Pregnancy
Pregnancy Complications, Infectious - epidemiology
Risk factors
Social Change
Socioeconomic Factors
Substance Abuse, Intravenous - complications
Ukraine - epidemiology
Abstract
Present and immediately foreseeable medical knowledge suggest that HIV infection cannot be avoided by vaccination and that an affordable cure for the resulting syndrome, AIDS, is a long way off. There is a strong possibility that Ukraine is confronted by an HIV epidemic which will spread into the general population and that the most common mode of transmission will be through heterosexual intercourse. The epidemic in the Ukraine is currently concentrated among intravenous drug users. It is estimated that between 60,000 and 180,000 people may currently be infected. In present economic and social circumstances there are many features of Ukrainian society that may add to the probability of the epidemic becoming widespread in the general population. It is likely that this process may have already commenced. The result of this will be numerous additional deaths and illness over the short (5 year) (19,000-23,000 deaths), medium (10-15 year) (61,000-111,000), and longer terms (>20 year) (in excess of 40,000-160,000 deaths). The research reported here was undertaken in 1997-8 and describes the potential medium to long term social and economic impact of an HIV/AIDS epidemic in Ukraine. Using the concepts of risk environment, susceptibility and vulnerability, it reports the problems which might be expected to develop in relation to care of excess orphans, the elderly, vulnerable households and regions as well as among those working in the "third sector", a social sector upon which exponents of the importance of developing sound "civil society" in "transitional economies" place heavy emphasis.
PubMed ID
11037225 View in PubMed
Less detail

14 records – page 1 of 2.